Medicare Enrolled

Dr. James Wilson, MD

Pulmonary Disease · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
6124 W PARKER RD, Plano, TX 75093
2147781075
In practice since 2007 (18 years)
NPI: 1841400520 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wilson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wilson

Dr. James Wilson is a pulmonary disease in Plano, TX, with 18 years in practice. Based on federal Medicare data, Dr. Wilson performed 1,634 Medicare services across 1,010 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wilson received a total of $54,384 from 56 pharmaceutical and/or device companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wilson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 28% volume in TX$ $54,384 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,634
Medicare services
Top 28% in TX for pulmonary disease
1,010
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~91 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity400$93$718
Hospital follow-up visit, moderate complexity239$62$500
Critical care, first 30-74 min141$166$1,534
Remote patient monitoring management, 20 min/month113$38$219
Office visit, established patient (20-29 min)110$64$473
Remote patient monitoring device, 30 days105$38$391
Office visit, established patient (30-39 min)101$93$693
Test to measure expiratory airflow and volume changes before and after medication administration60$29$272
Hospital follow-up visit, low complexity57$39$272
Initial hospital admission, high complexity56$131$1,389
Test to measure expiratory airflow and volume51$20$189
Test to determine lung volumes using sensors51$41$379
Test to examine how well the lungs exchange gases51$41$399
Initial hospital admission, moderate complexity44$98$948
New patient office visit (30-44 min)17$87$592
New patient office visit (45-59 min)13$130$957
Office visit, established patient (10-19 min)13$44$257
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes12$65$705
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$54,384
Total received (2018-2024)
Avg $7,769/year across 7 years
Top 6% in TX for pulmonary disease
56
Companies
786
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33,744 (62.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,574 (21.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,066 (16.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,254
2023
$5,842
2022
$17,071
2021
$10,622
2020
$10,822
2019
$6,079
2018
$1,694

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mylan Specialty L.P.
$27,384
AstraZeneca Pharmaceuticals LP
$16,479
GlaxoSmithKline, LLC.
$2,854
Insmed, Inc.
$699
Mallinckrodt Hospital Products Inc.
$614
Electromed, Inc.
$547
Boehringer Ingelheim Pharmaceuticals, Inc.
$481
Grifols USA, LLC
$470
Regeneron Healthcare Solutions, Inc.
$417
Takeda Pharmaceuticals U.S.A., Inc.
$409
Janssen Pharmaceuticals, Inc
$406
Merck Sharp & Dohme LLC
$383
Merck Sharp & Dohme Corporation
$325
Baxter Healthcare
$317
Advanced Respiratory, Inc
$305
GENZYME CORPORATION
$262
Gilead Sciences, Inc.
$196
United Therapeutics Corporation
$135
Actelion Pharmaceuticals US, Inc.
$133
Paratek Pharmaceuticals, Inc.
$133
Novartis Pharmaceuticals Corporation
$127
ADVANCED RESPIRATORY, INC
$116
Sunovion Pharmaceuticals Inc.
$116
ANI Pharmaceuticals, Inc.
$80
Exeltis, USA Inc.
$80
Shire North American Group Inc
$60
Chiesi USA, Inc.
$59
Philips Electronics North America Corporation
$53
Ambu Inc.
$45
Mayne Pharma Inc.
$43
Allergan Inc.
$42
PFIZER INC.
$40
Edwards Lifesciences Corporation
$37
Inari Medical, Inc.
$36
Mallinckrodt Enterprises LLC
$34
Teva Pharmaceuticals USA, Inc.
$33
Boston Scientific Corporation
$31
Vifor Pharma, Inc.
$30
AbbVie Inc.
$29
Philips North America LLC
$29
Tactile Systems Technology Inc
$27
Fisher & Paykel Healthcare Inc
$26
Nabriva Therapeutics, plc
$25
Vapotherm Inc
$24
Mallinckrodt LLC
$23
ABBVIE INC.
$22
Amgen Inc.
$22
Inogen, Inc.
$21
Inspire Medical Systems, Inc.
$19
PORTOLA PHARMACEUTICALS, INC.
$18
Cumberland Pharmaceuticals, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$16
Olympus America Inc.
$15
Ceribell, Inc.
$13
Circassia Pharmaceuticals Inc
$13
Veran Medical Technologies, Inc.
$13
Top 3 companies account for 85.9% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (8874) inCourage · (AK6) Vest Therapy · 120V · 60Hz · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CARDENE · CHANTIX · CINQAIR · CLEVIPREX · CUVITRU · DIFICID · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EXALT Model D · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · Flexitouch Plus · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · InogenOne · KEYTRUDA · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · Prolastin-C Liquid · RECARBRIO · S · SMARTVEST · SPIRIVA RESPIMAT · SPiN Thoracic Navigation System · STIOLTO RESPIMAT · SYMBICORT · Spin · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vibativ · XARELTO · XOLAIR · Xenleta · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for pulmonary disease in TX.

Equivalent to $3,328 per 100 Medicare services performed
Looking for a pulmonary disease in Plano?
Compare pulmonary diseases in the Plano area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
119
Per 100K population
10.7
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wilson is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), and high industry engagement (speaking/promotional, top 6%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wilson experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Wilson performed 400 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wilson receive payments from pharmaceutical companies?
Yes. Dr. Wilson received a total of $54,384 from 56 companies across 786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilson's costs compare to other pulmonary diseases in Plano?
Dr. Wilson's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →